Investment
Features
FeesSafety
Academy
More
Pluang+

Compare James Hardie Industries plc. Ordinary Shares (JHX) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance

James Hardie Industries plc. Ordinary SharesTrade
Dr. Reddy's Laboratories Ltd Common StockTrade

Price performance (Past 24H)

Key statistics

James Hardie Industries plc. Ordinary Shares vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? James Hardie Industries plc. Ordinary Shares trades at $24.56 (market cap $14.32B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: James Hardie Industries plc. Ordinary Shares is the larger of the two by market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while James Hardie Industries plc. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold James Hardie Industries plc. Ordinary Shares for 6 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.

JHXRDY
Market Cap
$14.32B$10.78B
Volume
5,683,8202,724,343
Sector
Basic MaterialsHealth
52-Week High
$31.08$15.38
52-Week Low
$16.69$11.38
Typical Hold Time
6 Days0 Days
Enterprise Value
$18.55B$10.68B
Dividend Yield
—0.65%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

James Hardie Industries plc. Ordinary Shares

James Hardie Industries (JHX) trades at $24.67, down 0.36% with a bearish technical outlook. The stock shows mixed fundamentals with a high P/E ratio of 112.14 but strong revenue growth from $3.88B to $5.4B projected. Recent earnings beat expectations in Q2 2026, and the company completed strategic divestitures including the $980M Fermacell sale to Holcim. Analyst sentiment remains positive with 70.59% buy ratings and a $34 consensus price target representing 38% upside potential.

JHX presents a growth story with expanding revenues but faces profitability compression as net margins decline from 10.93% to 2.69%. The stock's high valuation multiples require strong execution to justify. Key risks include integration challenges from recent acquisitions, rising debt levels, and housing market sensitivity. Institutional ownership shows mixed signals with State Street reducing its position while short interest increased 47.8% in September 2026.

Dr. Reddy's Laboratories Ltd Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

JHX

No sentiment data available yet.

RDY
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About James Hardie Industries plc. Ordinary Shares

James Hardie manufactures fiber cement products for residential and commercial construction. Its portfolio includes exterior siding, interior boards, and other building materials.

Read more on JHX →

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →